BIOL Historical PE Ratio image   This BIOL PE ratio history page last updated 3/1/2023
BIOL Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/10/2022
1.57-1.10-4.40NA
Q2 2022
8/11/2022
5.53-0.91-3.64NA
Q1 2022
5/12/2022
3.42-0.77-3.08NA
Q4 2021
3/17/2022
9.75-0.75-3.00NA
Q3 2021
11/10/2021
15.00-0.50-2.00NA
Q2 2021
8/12/2021
15.75-0.50-2.00NA
Q1 2021
5/13/2021
14.50-1.50-6.00NA
Q4 2020
3/25/2021
24.00-1.75-7.00NA
Q3 2020
11/12/2020
7.75-5.25-21.00NA
Q2 2020
8/13/2020
10.00-3.00-12.00NA
Q1 2020
5/7/2020
10.50-4.75-19.00NA
Q4 2019
3/26/2020
13.25-3.25-13.00NA
Q3 2019
11/6/2019
14.50-6.25-25.00NA
Q2 2019
8/8/2019
38.75-3.25-13.00NA
Q1 2019
5/9/2019
54.00-3.75-15.00NA
Q4 2018
3/5/2019
62.75-3.25-13.00NA
Q3 2018
11/13/2018
35.00-4.75-19.00NA
Q2 2018
8/8/2018
30.00-5.00-20.00NA
Q1 2018
5/2/2018
46.25-1.00-4.00NA
Q4 2017
3/14/2018
57.50-1.00-4.00NA
Q3 2017
11/1/2017
93.75-1.25-5.00NA
Q2 2017
8/7/2017
102.50-1.25-5.00NA
Q1 2017
5/3/2017
156.25-1.25-5.00NA
Q4 2016
3/8/2017
171.25-1.25-5.00NA
Q3 2016
11/8/2016
181.25-1.00-4.00NA
Q2 2016
8/1/2016
150.00-1.00-4.00NA
Q1 2016
5/9/2016
173.75-1.50-6.00NA
Q4 2015
3/9/2016
118.75-0.50-2.00NA
Q3 2015
11/4/2015
116.25-2.00-8.00NA
Q2 2015
8/5/2015
180.00-2.50-10.00NA
Q1 2015
4/30/2015
253.75-0.08-0.32NA
Q4 2014
3/4/2015
243.75-0.06-0.24NA
Q3 2014
11/4/2014
303.75-0.07-0.28NA
Q2 2014
8/7/2014
277.50-0.17-0.68NA
Q1 2014
5/12/2014
245.00-0.11-0.44NA
Q4 2013
3/5/2014
401.25-0.04-0.16NA
Q3 2013
11/11/2013
230.00-0.10-0.40NA
Q2 2013
8/7/2013
422.50-0.06-0.24NA
Q1 2013
5/7/2013
627.50-0.06-0.24NA
Q4 2012
3/6/2013
536.250.030.12>500
Q3 2012
11/5/2012
243.75-0.02-0.08NA
Q2 2012
8/8/2012
205.00-0.04-0.16NA
BIOL PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/10/2022
1.57-1.10-3.53NA
Q2 2022
8/11/2022
5.53-0.91-2.93NA
Q1 2022
5/12/2022
3.42-0.77-2.52NA
Q4 2021
3/17/2022
9.75-0.75-3.25NA
Q3 2021
11/10/2021
15.00-0.50-4.25NA
Q2 2021
8/12/2021
15.75-0.50-9.00NA
Q1 2021
5/13/2021
14.50-1.50-11.50NA
Q4 2020
3/25/2021
24.00-1.75-14.75NA
Q3 2020
11/12/2020
7.75-5.25-16.25NA
Q2 2020
8/13/2020
10.00-3.00-17.25NA
Q1 2020
5/7/2020
10.50-4.75-17.50NA
Q4 2019
3/26/2020
13.25-3.25-16.50NA
Q3 2019
11/6/2019
14.50-6.25-16.50NA
Q2 2019
8/8/2019
38.75-3.25-15.00NA
Q1 2019
5/9/2019
54.00-3.75-16.75NA
Q4 2018
3/5/2019
62.75-3.25-14.00NA
Q3 2018
11/13/2018
35.00-4.75-11.75NA
Q2 2018
8/8/2018
30.00-5.00-8.25NA
Q1 2018
5/2/2018
46.25-1.00-4.50NA
Q4 2017
3/14/2018
57.50-1.00-4.75NA
Q3 2017
11/1/2017
93.75-1.25-5.00NA
Q2 2017
8/7/2017
102.50-1.25-4.75NA
Q1 2017
5/3/2017
156.25-1.25-4.50NA
Q4 2016
3/8/2017
171.25-1.25-4.75NA
Q3 2016
11/8/2016
181.25-1.00-4.00NA
Q2 2016
8/1/2016
150.00-1.00-5.00NA
Q1 2016
5/9/2016
173.75-1.50-6.50NA
Q4 2015
3/9/2016
118.75-0.50-5.08NA
Q3 2015
11/4/2015
116.25-2.00-4.64NA
Q2 2015
8/5/2015
180.00-2.50-2.71NA
Q1 2015
4/30/2015
253.75-0.08-0.38NA
Q4 2014
3/4/2015
243.75-0.06-0.41NA
Q3 2014
11/4/2014
303.75-0.07-0.39NA
Q2 2014
8/7/2014
277.50-0.17-0.42NA
Q1 2014
5/12/2014
245.00-0.11-0.31NA
Q4 2013
3/5/2014
401.25-0.04-0.26NA
Q3 2013
11/11/2013
230.00-0.10-0.19NA
Q2 2013
8/7/2013
422.50-0.06-0.11NA
Q1 2013
5/7/2013
627.50-0.06-0.09NA
Q4 2012
3/6/2013
536.250.03NANA
Q3 2012
11/5/2012
243.75-0.02NANA
Q2 2012
8/8/2012
205.00-0.04NANA
Quotes delayed 20 minutes

Email EnvelopeFree BIOL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biolase (BIOL) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BIOR PE Ratio History
BIVI PE Ratio History
BKD PE Ratio History
BLCM PE Ratio History
BLFS PE Ratio History
BLI PE Ratio History
BLPH PE Ratio History
BLUE PE Ratio History
BMEA PE Ratio History
BMRA PE Ratio History
How should the BIOL historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Biolase. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BIOL Historical PE Ratio page.

What is the average historical PE for BIOL based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BIOL historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for BIOL based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BIOL historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the BIOL Historical PE Ratio information for Biolase' stock. The average BIOL historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BIOL historical PE based on this TTM earnings result method is NA. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BIOL historical PE result, against the recent PE: when this page was posted on 2/28/2023, the most recent closing price for BIOL had been 0.51, and the most recent quarterly earnings result, annualized, was 0.12. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on BIOL or any other given stock, valuation analysis for BIOL can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Biolase PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BIOL. Thanks for visiting, and the next time you need to research BIOL Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: PYX Options Chain, Top Ten Hedge Funds Holding WBIG, Top Ten Hedge Funds Holding EFAV.

 

BIOL Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.